Results 271 to 280 of about 14,398,598 (290)
Some of the next articles are maybe not open access.

COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors

MAbs, 2020
Pui Seto
exaly  

Characterization of Bispecific T-cell Engager (BiTE®) Antibodies with a High-Capacity T-cell Dependent Cellular Cytotoxicity (TDCC) Assay

SLAS Discovery, 2015
Paul Wang
exaly  

BISPECIFIC IgG ANTIBODIES AS T CELL ENGAGERS

2014
BAKKER ALEXANDER BERTHOLD HENDRIK   +2 more
openaire   +6 more sources

T cell engagers in autoimmune diseases

Nature Reviews Immunology
Ricardo Grieshaber-Bouyer   +3 more
openaire   +1 more source

The expanding success of T cell-engaging bispecific antibodies

Nature Cancer, 2023
openaire   +2 more sources

Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies

Frontiers in Immunology
Zinnia P Parra-Guillen   +2 more
exaly  

Von CAR-T zu T-cell-Engager

Zeitschrift für Rheumatologie
Matthias Pierer, David Simon
openaire   +1 more source

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

2017
RAUM TOBIAS   +9 more
openaire   +4 more sources

VECTORIZATION OF MUC1 T CELL ENGAGER

2022
MARCHAND JEAN-BAPTISTE, REMY CHRISTELLE
openaire   +1 more source

A Transformable Supramolecular Bispecific Cell Engager for Augmenting Natural Killer and T Cell-Based Cancer Immunotherapy

Advanced Materials
Yumiao Chen, Jie Gao, Zhimou Yang
exaly  
t-lymphocytes
humans
immunotherapy
neoplasms
3. good health
antibodies, bispecific
animals
receptors, antigen, t-cell
a1
previous   26  27  28  29  

Home - About - Disclaimer - Privacy